Telesis (Drug Discovery) is Drug Discovery in United States that focus on deadly solid tumors business. Founded in 2015. They cover business area such as developer, medical drug, patient, solid tumor, pancreatic cancer, cancer cell, cell death, no impact, normal cell, doctor, PDAC.
2015
( 9 years old in 2024 )
Deadly Solid Tumors
-
3711 Market Street
University City Science Center, Suite 800
Philadelphia, PA 19104
United States
Private
developermedical drugpatientsolid tumorpancreatic cancercancer cellcell deathno impactnormal celldoctorPDAC
* We use standard office opening hours in near Telesis (Drug Discovery)'s location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Telesis (Drug Discovery) is Drug Discovery business from United States that founded in 2015 (9 years old in 2024), Telesis (Drug Discovery) business is focusing on Deadly Solid Tumors.
Telesis (Drug Discovery) headquarter office and corporate office address is located in 3711 Market Street University City Science Center, Suite 800 Philadelphia, PA 19104 United States.
Telesis (Drug Discovery) was founded in United States.
In 2024, Telesis (Drug Discovery) is currently focus on deadly solid tumors sector.
Above is snippet of Google Trends for "deadly solid tumors" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Telesis (Drug Discovery), any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
